Promotion of fas-mediated apoptosis in type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement

The death receptor pathway is coupled to the mitochondria apoptosis pathway. However, mitochondrial participation, which is stimulated by Bid but suppressed by Bcl-2/Bcl-X-L, is required in certain cells (Type 11), but not in others (Type 1). While these differences were originally characterized in the lymphoid cell lines, the typical Type 11 cells are represented by hepatocytes in vivo. The molecular mechanisms that distinguish Type 11 from Type I cells and the regulation are not fully understood. Fas can be sequestered by the HGF receptor c-Met and high doses of HGF can promote cell death by freeing Fas from c-Met complex. We thus reasoned that treatment of the Type 11 cells with high doses of HGF could enhance Fas-mediated apoptosis and spare the mitochondria amplification. Indeed, such treatment led to increased apoptosis in Type 11 lymphoid cells, which could not be blocked by Bcl-X-L. Moreover, significant hepatocyte apoptosis was induced by this scheme in the absence of Bid with increased dissociation of Fas from c-Met. These findings indicate that high doses of HGF could be used to promote apoptosis in Type 11 cells bypassing the requirement for mitochondria activation.